First Light Diagnostics develops innovative medical diagnostic products for the detection of Healthcare Associated Infections.
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 1, 2015 | Grant | $4M | 1 | National Institutes of Health | — | Detail |
Mar 1, 2011 | Grant | $3M | 1 | National Institutes of Health | — | Detail |
Sep 18, 2008 | Grant | $600K | 1 | National Institutes of Health | — | Detail |
Aug 18, 2008 | Grant | $300K | 1 | National Institutes of Health | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |